Co-delivery of proteins and small molecule drugs for mitochondria-targeted combination therapy

Chem Commun (Camb). 2021 Apr 4;57(26):3215-3218. doi: 10.1039/d0cc08020a. Epub 2021 Mar 1.

Abstract

Herein, we report the first use of gluthathione (GSH)-responsive nanogel-based carriers for mitochondria-targeted delivery of functional proteins and antibodies. We further demonstrated the successful co-encapsulation of a protein and small molecule (RNase A/Doxorubicin) in dual-cargo nanocapsules for mitochondria-targeted combination therapy.

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Doxorubicin / administration & dosage*
  • Drug Delivery Systems
  • Glutathione / chemistry
  • HeLa Cells
  • Humans
  • Mitochondria / chemistry
  • Mitochondria / drug effects*
  • Nanocapsules / chemistry*
  • Ribonuclease, Pancreatic / administration & dosage*

Substances

  • Antibiotics, Antineoplastic
  • Nanocapsules
  • Doxorubicin
  • Ribonuclease, Pancreatic
  • Glutathione